World's Best Scientists 2026 revealed!
Robert S. Kerbel

Robert S. Kerbel

Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
126
Citations
65748
World Ranking
2933
National Ranking
121

Robert S. Kerbel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert S. Kerbel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 495 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert S. Kerbel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert S. Kerbel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Robert S. Kerbel is affiliated with the University of Toronto in Canada. Their research activities span multiple fields, primarily in Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions to Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, and Immunology.

The main topics covered in their work include:

  • Angiogenesis and VEGF in Cancer
  • Cancer Immunotherapy and Biomarkers
  • Cell Adhesion Molecules Research
  • Immunotherapy and Immune Responses
  • Prostate Cancer Treatment and Research
  • Cancer Genomics and Diagnostics
  • Renal cell carcinoma treatment

Frequent co-authors in their publications include:

  • Kabir A. Khan (8 publications)
  • William Cruz-Muñoz (4 publications)
  • Shan Man (3 publications)
  • Hanzhi Wang (3 publications)
  • Xiaoyong Huang (3 publications)

The scientist has published several papers in recurring venues, with multiple works appearing in:

  • Cancer Research (5 publications)
  • EMBO Molecular Medicine (3 publications)
  • Nature Reviews Clinical Oncology
  • Science Immunology
  • npj Breast Cancer

Notable recent publications include:

  • "Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials," 2024, Nature Reviews Clinical Oncology
  • "Tumors resurrect an embryonic vascular program to escape immunity," 2022, Science Immunology
  • "Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer," 2021, EMBO Molecular Medicine
  • "Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer," 2020, npj Breast Cancer
  • "Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers," 2020, EMBO Molecular Medicine

Best Publications

  • Angiogenesis as a therapeutic target

    Napoleone Ferrara;Robert S. Kerbel

  • Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

    John M.L. Ebos;Christina R. Lee;William Cruz-Munoz;Georg A. Bjarnason

  • Clinical translation of angiogenesis inhibitors.

    Robert Kerbel;Judah Folkman

  • The anti-angiogenic basis of metronomic chemotherapy

    Robert S. Kerbel;Barton A. Kamen

  • Tumor angiogenesis: past, present and the near future.

    Robert S. Kerbel

  • Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

    Giannoula Klement;Sylvain Baruchel;Janusz Rak;Shan Man

  • Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

    Alicia M. Viloria Petit;Janusz Rak;Mien Chie Hung;Patricia Rockwell

  • Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan

    Charles H. Graham;Teresa S. Hawley;Robert C. Hawley;John R. MacDougall

  • Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

    J. Rak;Y. Mitsuhashi;L. Bayko;J. Filmus

  • Antiangiogenic therapy in oncology: current status and future directions.

    Gordon C Jayson;Robert Kerbel;Lee M Ellis;Adrian L Harris

  • Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

    John M. L. Ebos;Robert S. Kerbel

  • Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

    Khalid Al-Nedawi;Brian Meehan;Robert S. Kerbel;Anthony C. Allison

  • The multifaceted circulating endothelial cell in cancer: towards marker and target identification

    Francesco Bertolini;Yuval Shaked;Patrizia Mancuso;Robert S. Kerbel

  • Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

    Yuval Shaked;Alessia Ciarrocchi;Marcela Franco;Christina R. Lee

  • Acquired Resistance to the Antitumor Effect of Epidermal Growth Factor Receptor-blocking Antibodies in Vivo A Role for Altered Tumor Angiogenesis

    Alicia Viloria-Petit;Tania Crombet;Serge Jothy;Daniel Hicklin

  • E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1

    Brad St. Croix;Capucine Sheehan;Janusz W. Rak;Vivi Ann Flørenes

  • A role for survivin in chemoresistance of endothelial cells mediated by VEGF.

    Jennifer Tran;Zubin Master;Joanne L. Yu;Janusz Rak

  • Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents.

    Robert S. Kerbel

  • Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

    Francesco Bertolini;Saki Paul;Patrizia Mancuso;Silvia Monestiroli

  • Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?

    Robert S. Kerbel

Frequent Co-Authors

Francesco Bertolini
Francesco Bertolini European Institute of Oncology
Daniel J. Hicklin
Daniel J. Hicklin Eli Lilly (United States)
F. Stuart Foster
F. Stuart Foster University of Toronto
Jorge Filmus
Jorge Filmus Sunnybrook Health Science Centre
Daniel J. Dumont
Daniel J. Dumont University of Toronto
James W. Dennis
James W. Dennis Lunenfeld-Tanenbaum Research Institute
Martin L. Breitman
Martin L. Breitman University of Toronto
Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
Peter B. Vermeulen
Peter B. Vermeulen University of Antwerp
Romano Danesi
Romano Danesi University of Pisa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying Medicine in the USA, there are many alternative online degrees and career pathways to consider—especially in nursing, which remains in high demand nationwide. For those already holding a nursing license, advancing your career can be made more affordable through the online nursing doctorate programs. These programs allow working professionals to pursue advanced practice and leadership roles while maintaining flexibility.

For registered nurses looking to complete their bachelor's degree, the cheapest online bsn programs are a cost-effective way to boost credentials and expand career opportunities. If you're coming from a non-nursing background but want to enter the field quickly, consider the online direct entry msn programs for non-nursing majors. These accelerated options help students transition into nursing without prior experience.

Finally, applicants concerned about competitiveness may find more accessible entry points through nursing schools with high acceptance rates. Exploring these options can help you fast-track your journey into healthcare, regardless of your starting point.

Best Scientists Citing Robert S. Kerbel

Trending Scientists